Search

everythinglearnresearchcommunity

for

Search:↓

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Older patients sticking to their prostate medication saw lasting health benefits.

"Brave New World" explores the dangers of losing individuality in a future, technologically advanced society that prioritizes collective stability over personal freedom.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

The document reports the 19th global case of a rare skin condition in a patient from Colombia.

Amino acid supplements may not be necessary for all women with chronic hair loss.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The congress discussed fat grafting, stem cells, and safety in plastic and regenerative surgery, with plans for a future meeting in Chicago.

Low-level light therapy can help with hair growth and preventing hair loss.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib shows promise in treating severe hair loss.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Public interest in finasteride's sexual side effects has significantly increased, highlighting the need for better patient discussions.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Young adults have about 230,000 tactile nerve fibers, decreasing 5-8% per decade with age.

Intravital imaging helps us better understand stem cells in their natural environment and could improve knowledge of organ regeneration and cancer development.

Adolescents with severe alopecia incur significantly higher healthcare costs.

The skin has about 230,000 touch-sensitive nerve fibers, with high concentrations in the hands and face.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Many 20th century politicians had skin conditions, with vitiligo being most common, affecting their image and political life.

Semaglutide does not significantly increase the risk of hair loss.